Organogenesis Holdings (ORGO) Operating Expenses (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Operating Expenses of $106.1 million for Q1 2026, down 6.45% year-over-year from $113.4 million in Q1 2025, and down 75.43% quarter-over-quarter from $431.9 million in Q4 2025.
Organogenesis Holdings (ORGO) Operating Expenses (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Operating Expenses history runs 11 years deep, the most recent figure standing at $106.1 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 6.45% year-over-year to $106.1 million; the TTM figure through Mar 2026 stood at $781.7 million (up 289.91% YoY), while the FY2025 annual figure was $519.5 million, up 348.83% from the prior year.
- Operating Expenses for Q1 2026 stood at $106.1 million, down from $431.9 million in the prior quarter.
- The five-year high for Operating Expenses was $431.9 million in Q4 2025, with the low at $26.8 million in Q3 2024.
- The 5-year median for Operating Expenses is $85.0 million (2023), against an average of $106.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses plunged 82.71% in 2024, then surged 1290.84% in 2025.
- Organogenesis Holdings' Operating Expenses stood at $79.7 million in 2022, then jumped by 125.42% to $179.6 million in 2023, then slumped by 82.71% to $31.1 million in 2024, then soared by 1290.84% to $431.9 million in 2025, then sank by 75.43% to $106.1 million in 2026.
- Business Quant data shows ORGO's Operating Expenses at $106.1 million in Q1 2026, $431.9 million in Q4 2025, and $130.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Organogenesis Holdings | 242.55 Mn | 195.71 Mn | 20.08 Mn | 94.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.75 Mn |
| Mar 31, 2026 | 106.12 Mn |
| Dec 31, 2025 | 431.87 Mn |
| Sep 30, 2025 | 130.14 Mn |
| Jun 30, 2025 | 113.58 Mn |
| Mar 31, 2025 | 113.44 Mn |
| Dec 31, 2024 | 31.05 Mn |
| Sep 30, 2024 | 26.80 Mn |
| Jun 30, 2024 | 29.20 Mn |
| Mar 31, 2024 | 85.13 Mn |
| Dec 31, 2023 | 179.63 Mn |
| Sep 30, 2023 | 74.69 Mn |
| Jun 30, 2023 | 81.26 Mn |
| Mar 31, 2023 | 85.04 Mn |
| Dec 31, 2022 | 79.69 Mn |
| Sep 30, 2022 | 88.90 Mn |
| Jun 30, 2022 | 82.81 Mn |
| Mar 31, 2022 | 72.17 Mn |
| Dec 31, 2021 | 75.51 Mn |
| Sep 30, 2021 | 71.32 Mn |